President and CEO of Inhibikase Therapeutics, Inc. (U.S.: Nasdaq:IKT), Werner Milton H., buys 23,589 shares worth $46,558

According to Inhibikase Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Nov 19 08:13 AM, company President and CEO, Werner Milton H. disclosed buying 23,589 shares at a cost of $1.97. At the time of this transaction (Nov 17), this trade was worth $46,558 in total. As of Nov 17, Werner Milton H. now owns 23,589 shares in total worth about $44,819.1.

For the last few recent trades made by Inhibikase Therapeutics, Inc. (U.S.: Nasdaq:IKT) President and CEO, Werner Milton H., we have the following information:

Posted by George Daniels on Friday November 19 2021, 10:31 AM EST. All trademarks acknowledged. Filed under Business, Stocks. Comments and Trackbacks closed. Follow responses: RSS 2.0